Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients.
de Masson A, Darbord D, Dobos G, Boisson M, Roelens M, Ram-Wolff C, Cassius C, Le Buanec H, de la Grange P, Jouenne F, Louveau B, Sadoux A, Bouaziz JD, Marie-Cardine A, Bagot M, Moins-Teisserenc H, Mourah S, Battistella M.
de Masson A, et al. Among authors: louveau b.
Blood. 2022 Mar 24;139(12):1820-1832. doi: 10.1182/blood.2021013341.
Blood. 2022.
PMID: 34905599
Free article.